Journals / JAREM / 2014 / Cilt: 4 - Sayı: 3

Relationship between Carotid Intima-Media Thickness and Proteinuria in Patients with Metabolic Syndrome

Hipertansif Metabolik Sendromlu Hastalarda Karotis İntima-Media Kalınlığı ve Proteinüri İlişkisi

Journal
JAREM
Pages
115–120
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All biochemical data were analyzed retrospectively.Results: Overall, 61.9% of patients were women; 38.1% of them were men.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to find the relationship between intima-media thickness and proteinuria, which are early findings of atherosclerosis and renal failure in patients with metabolic syndrome.Methods: In our study, 63 patients with metabolic syndrome and 26 healthy subjects, as the control group, were involved.
📊
Key Findings & Data:Both groups were over 40 years old in the study.
💡
Conclusion & Impact:All biochemical data were analyzed retrospectively.Results: Overall, 61.9% of patients were women; 38.1% of them were men.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to find the relationship between intima-media thickness and proteinuria, which are early findings of atherosclerosis and renal failure in patients with metabolic syndrome.Methods: In our study, 63 patients with metabolic syndrome and 26 healthy subjects, as the control group, were involved. Both groups were over 40 years old in the study. In both groups, carotid intima-media thickness was measured with B-mode ultrasonography. All biochemical data were analyzed retrospectively.Results: Overall, 61.9% of patients were women; 38.1% of them were men. Also, 61.54% of the control group was female; 38.46% of them were men. Carotid intima-media thickness, level of glucose, urea, creatinine, high-density lipoprotein (HDL) cholesterol, uric acid, C-reactive protein (CRP), retinopathy (p<0.001), age (p=0.017), triglyceride (p=0.022), glomerular filtration rate (GFR) (p=0.029), proteinuria (p=0.035), abdominal circumference (p=0.006), body mass index (BMI) (p=0.047), and thyroid-stimulating hormone (TSH) (p=0.013) were significantly higher in patients with metabolic syndrome.Conclusion: In the patients with metabolic syndrome, carotid intima-media thickness and proteinuria are precursors of atherosclerosis. These findings are important predictions for the development of type II diabetes mellitus, coronary heart disease, and chronic kidney disease.

Özet

Amaç: Kliniğimize başvuran metabolik sendromlu hastalarda aterosklerozun ve böbrek yetmezliğinin erken bulgularından olan karotis intima-media kalınlığı ve proteinüri ilişkisi değerlendirildi.Yöntemler: Çalışmamızda kliniğimize başvuran metabolik sendromlu 40 yaş üstü toplam 63 hasta ve 26 kontrol grubu değerlendirmeye alındı. Her iki grupta karotis intima-media kalınlığı B mod doppler ultrasonografi ile değerlendirilirken, biyokimyasal veriler retrospektif olarak laboratuarlarımızda incelendi.Bulgular: Hastaların %61,9'u kadın, %38,1'i erkek toplam 63 kişiden oluşurken, kontrol grubu %61,54 kadın, %38,46 erkek toplam 26 kişiden oluşmaktaydı. Karotis intima- media kalınlığı, glukoz, üre, kreatinin, yüksek dansiteli (HDL) kolesterol, ürik asit, C-reaktif protein (CRP), retinopati (p<0,001), yaş (p=0,017), trigliserit (p=0,022), glomerüler fitrasyon hızı (GFR) (p=0,029), proteinüri (p=0,035), bel çevresi (p=0,006), vücut kitle indeksi (BMI) (p=0,047), tiroid stimulan hormon (TSH) (p=0,013) değerleri metabolik sendromlu hastalarımız lehine anlamlıydı.Sonuç: Metabolik sendromlularda karotis intima-media kalınlığı ve proteinüri aterosklerozun habercisi olup, Tip 2 DM, koroner kalp hastalığı ve kronik böbrek yetmezliğinin ön uyaranıdır.

🔖

Cite This Article

AYAR, Y., ATALAY, H., BÖYÜK, B., SAYILAR, E. I., ŞAHİN, A. B., GÖMLEKSİZ, M. R., KARADUMAN, R., ÇELEBİ, A. (2014). Relationship between Carotid Intima-Media Thickness and Proteinuria in Patients with Metabolic Syndrome. JAREM, Cilt: 4 - Sayı: 3, 115–120. https://ajindex.com/articles/210971

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Hamuryudan V, Sonsuz A, Yazıcı H. Cerrahpaşa İç Hastalıkları. Nobel Tıp Kitabevi; 1.baskı, İstanbul: Nobel Tıp Kitabevi; 2005
  2. Türkiye Endokrinoloji ve Metabolizma Derneği. Metabolik Sendrom Kılavuzu.Ankara: BAYT; 2009
  3. Ronald A. Codario MD. Tip 2 Diyabet, Pre-Diyabet ve Metabolik Sendrom. 2005, çeviri, Karşıdağ K. s:58-62
  4. Reaven GM. Role of insülin resistance in human disease. Diabetes 1988; 37: 1595-607. [CrossRef] 5. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-68. [CrossRef] 6. Vivian EM. Type 2 diabetes in children and adolescents--the next epidemic? Curr Med Res Opin 2006; 22: 297-306. [CrossRef] 7. Haffner SM, Mykkannen L, Festa A. İnsulin resistant prediabetic subjects have more atherogenic risk factors than insülin sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circul 2000; 101: 975-80. [CrossRef] 8. Cusi K, Maezono K, Osman A,Pendergrass M, Patti ME, Pratipanawatr T, et al. İnsulin resistance differentially affects the PI 3 kinaseand MAP kinase mediated signaling in human muscle. J Clin Invest 2000; 105: 311-20. [CrossRef] 9. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 2002; 90: 3-10. [CrossRef] 10. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN et al. Inhibition of PI 3 kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002; 277: 1794-9. [CrossRef] 11. Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insülin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002; 40: 937-43. [CrossRef] 12. Howard G, Bergman R, Wagenknecht LE. Ability of alternative indices of insülin sensitivity to predict cardiovascular risk: comparison with the 'minimal model.' Insulin Resistance Atherosclerosis Study (IRAS) Invistigators. Ann Epidemiol 1993; 8: 358-69. [CrossRef] 13. Levine TB, Levine AB. Metabolik Sendrom ve Kardiyovasküler Hastalıklar, Nobel Tıp Kitabevi, 1.baskı, İstanbul 2006, çeviri: Oğuz A. s:147-50
  5. Vogt BP, Souza PL, Minicucci MF, Martin LC, Barretti P, Caramori JT. Metabolic syndrome criteria as predictors of insulin resistance, Inflammation and mortality in chronic hemodialysis patients. Metab Syndr Relat Disord 2014; 6: 1-8
  6. Onat A, Yazıcı M, Hergenç G, Uyarel H, Esen AM, Karabulut A vd. Türk erişkinlerinde hafif böbrek fonksiyon bozukluğu: yay